Channick RN - Search Results

1

Risk assessment in pulmonary arterial hypertension: Insights from the GRIPHON study.

Sitbon O, Chin KM, Channick RN, Benza RL, Di Scala L, Gaine S, Ghofrani HA, Lang IM, McLaughlin VV, Preiss R, Rubin LJ, Simonneau G, Tapson VF, Galiè N, Hoeper MM. Sitbon O, et al. Among authors: channick rn. J Heart Lung Transplant. 2020 Apr;39(4):300-309. doi: 10.1016/j.healun.2019.12.013. Epub 2020 Jan 21. J Heart Lung Transplant. 2020. PMID: 32061506 Free article. Clinical Trial.

2

Combination therapy for pulmonary hypertension: a glimpse into the future?

Channick RN, Rubin LJ. Channick RN, et al. Crit Care Med. 2000 Mar;28(3):896-7. doi: 10.1097/00003246-200003000-00055. Crit Care Med. 2000. PMID: 10752856 No abstract available.

3

"High probability" perfusion lung scans in pulmonary venoocclusive disease.

Bailey CL, Channick RN, Auger WR, Fedullo PF, Kerr KM, Yung GL, Rubin LJ. Bailey CL, et al. Among authors: channick rn. Am J Respir Crit Care Med. 2000 Nov;162(5):1974-8. doi: 10.1164/ajrccm.162.5.2003045. Am J Respir Crit Care Med. 2000. PMID: 11069842

4

A new era in the treatment of primary pulmonary hypertension.

Bailey CL, Channick RN, Rubin LJ. Bailey CL, et al. Among authors: channick rn. Heart. 2001 Mar;85(3):251-2. doi: 10.1136/heart.85.3.251. Heart. 2001. PMID: 11179256 Free PMC article. No abstract available.

5

Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary hypertension: a placebo-controlled study.

Channick R, Badesch DB, Tapson VF, Simonneau G, Robbins I, Frost A, Roux S, Rainisio M, Bodin F, Rubin LJ. Channick R, et al. J Heart Lung Transplant. 2001 Feb;20(2):262-263. doi: 10.1016/s1053-2498(00)00606-9. J Heart Lung Transplant. 2001. PMID: 11250530 No abstract available.

6

Pulmonary vasoreactivity in PPH.

Robbins IM, Barst RJ, Channick RN, Rubin LJ. Robbins IM, et al. Among authors: channick rn. J Am Coll Cardiol. 2001 Oct;38(4):1267-8. doi: 10.1016/s0735-1097(01)01527-3. J Am Coll Cardiol. 2001. PMID: 11587028 Free article. No abstract available.

7

New and experimental therapies for pulmonary hypertension.

Channick RN, Rubin LJ. Channick RN, et al. Clin Chest Med. 2001 Sep;22(3):539-45. doi: 10.1016/s0272-5231(05)70290-2. Clin Chest Med. 2001. PMID: 11590847 Review.

8

Chronic thromboembolic pulmonary hypertension.

Fedullo PF, Auger WR, Channick RN, Kerr KM, Rubin LJ. Fedullo PF, et al. Among authors: channick rn. Clin Chest Med. 2001 Sep;22(3):561-81. doi: 10.1016/s0272-5231(05)70292-6. Clin Chest Med. 2001. PMID: 11590849 Review.

9

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study.

Channick RN, Simonneau G, Sitbon O, Robbins IM, Frost A, Tapson VF, Badesch DB, Roux S, Rainisio M, Bodin F, Rubin LJ. Channick RN, et al. Lancet. 2001 Oct 6;358(9288):1119-23. doi: 10.1016/S0140-6736(01)06250-X. Lancet. 2001. PMID: 11597664 Clinical Trial.

10

Outpatient inhaled nitric oxide in a patient with idiopathic pulmonary fibrosis: a bridge to lung transplantation.

Yung GL, Kriett JM, Jamieson SW, Johnson FW, Newhart J, Kinninger K, Channick RN. Yung GL, et al. Among authors: channick rn. J Heart Lung Transplant. 2001 Nov;20(11):1224-7. doi: 10.1016/s1053-2498(01)00304-7. J Heart Lung Transplant. 2001. PMID: 11704484

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

180 results

Search Page

Filters